SUVmin

2 trials

Sponsors

The First Affiliated Hospital of Harbin Medical University

Conditions

malignant solid tumorprostatic cancer

Unknown Phase

Comparison of new imaging agent Al[18F]-FAPI-04 with 18F-FDG in solid tumor imaging.

Active, not recruitingChiCTR2100051406

The First Affiliated Hospital of Harbin Medical Universitymalignant solid tumor

Start: 2021-05-01Updated: 2022-06-20

The value of 18F-SMA -1007 PET/CT in accurate assessment of biochemical recurrence of prostate cancer and its influence on clinical treatment decision

RecruitingChiCTR2100052238

The First Affiliated Hospital of Harbin Medical Universityprostatic cancer

Start: 2020-06-13Updated: 2022-10-17

Related Papers

<sup>18</sup>F-FAPI-04 PET/CT in the evaluation of ground-glass nodules less than 3 cm in diameter comparing to <sup>18</sup>F-FDG PET/CT.

2025-11-10

The value of habitat analysis based on <sup>18</sup>F-PSMA-1007 PET/CT images for prostate cancer risk grading.

2025-07-21

Clinical application of Al18F-NOTA-FAPI PET/CT in diagnosis and TNM staging of pancreatic adenocarcinoma, compared to 18F-FDG

Cancer Imaging2023-09-1214 citations